lunes, 1 de septiembre de 2014

Frontiers | Disrupted human–pathogen co-evolution: a model for disease | Evolutionary and Population Genetics

Frontiers | Disrupted human–pathogen co-evolution: a model for disease | Evolutionary and Population Genetics



HYPOTHESIS & THEORY ARTICLE

Front. Genet., 25 August 2014 | doi: 10.3389/fgene.2014.00290

Disrupted human–pathogen co-evolution: a model for disease

Nuri Kodaman1,2Rafal S. Sobota1,2Robertino Mera3Barbara G. Schneider3 and Scott M. Williams1*
  • 1Department of Genetics, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA
  • 2Department of Molecular Physiology and Biophysics, Center for Human Genetics Research, Vanderbilt University Medical Center, Nashville, TN, USA
  • 3Division of Gastroenterology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
A major goal in infectious disease research is to identify the human and pathogenic genetic variants that explain differences in microbial pathogenesis. However, neither pathogenic strain nor human genetic variation in isolation has proven adequate to explain the heterogeneity of disease pathology. We suggest that disrupted co-evolution between a pathogen and its human host can explain variation in disease outcomes, and that genome-by-genome interactions should therefore be incorporated into genetic models of disease caused by infectious agents. Genetic epidemiological studies that fail to take both the pathogen and host into account can lead to false and misleading conclusions about disease etiology. We discuss our model in the context of three pathogens, Helicobacter pylori,Mycobacterium tuberculosis and human papillomavirus, and generalize the conditions under which it may be applicable.

No hay comentarios:

Publicar un comentario